Download Files:
Products Details
Product Description
– HBV-IN-41 (compound 45) is a potent and orally active Hepatitis B Virus (HBV) inhibitor, with an EC50 of 0.027μM[1].
Web ID
– HY-156272
Shipping
– Room temperature
Molecular Formula
– C18H19ClFN5O3
References
– [1]Kou B, et al. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. J Med Chem. 2023 Oct 6.
CAS Number
– 1967002-25-0
Molecular Weight
– 407.83
SMILES
– C[C@H]1CN2C(CN1C(NC3=CC(Cl)=C(C=C3)F)=O)=C(C=N2)N4CCOCC4=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
